Published Nov 9, 2022

Eddie Martucci, CEO, Akili Interactive - Software that is the medicine

Eddie Martucci, CEO of Akili Interactive, explores the transformative potential of digital therapeutics, how game design principles led to the first FDA-approved video game for treating ADHD, and the role of data in revolutionizing patient care.
Episode Highlights
The Next Great Thing logo

Popular Clips

Episode Highlights

  • Digital Therapeutics

    Digital therapeutics represent a groundbreaking approach in healthcare, utilizing software to treat various medical conditions. introduces the concept, highlighting its potential to address issues like depression, anxiety, and chronic pain. defines digital therapeutics as "software that is the medicine," emphasizing its role alongside traditional treatments 1.

       

    FDA Approval

    Navigating the FDA approval process for digital therapeutics is as rigorous as for traditional medicines. Eddie explains that their product, EndeavorRx, underwent a drug-style review with five clinical trials and 600 patients 2. This rigorous process ensures the effectiveness and safety of digital treatments, building trust among doctors and patients.

       

    Collaborations

    Collaborations with pharmaceutical companies and research institutions are crucial for advancing digital therapeutics. Eddie mentions partnerships with companies like Shionogi and research collaborations with Cornell and Vanderbilt for treating Long COVID 3 4. These partnerships help validate and expand the reach of digital therapeutic solutions.

Related Episodes